Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, we offer novel therapies on a platform of affordable innovation.
We believe our strategic licensing partnerships will rapidly provide us wider global access and greater market penetration. More significantly, they will enable us to deliver breakthrough therapeutics to millions of patients the world over.